Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Flea and Tick Control Medication Market

Flea and Tick Control Medication Market Share

Report ID: GMI10734
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Flea and Tick Control Medication Market Share

The market is driven by continuous innovation and technological advancements. Leading companies in this field provide a comprehensive array of advanced medications, including oral medications and topical solutions, alongside strategic initiatives to maintain a competitive edge. These companies consistently invest in research and development to introduce new formulations and improve existing products, thereby enhancing efficacy and safety in preventing and controlling infestations.

Flea and Tick Control Medication Market Companies

Few of the prominent players operating in flea and tick control medication industry include:

Bayer AG
Boehringer Ingelheim International GmbH
Central Garden & Pet Company
Central Life Sciences
Ceva Santé Animale
Ecto Development LLC
Elanco Animal Health Incorporated
Hartz Mountain Corporation
Merck & Co., Inc.
Penn Veterinary Supply, Inc.
Promika LLC
PetIQ, LLC
Virbac S.A.
Zoetis Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global flea and tick control medication industry was valued at USD 6.7 billion in 2023 and is anticipated to register 7.1% CAGR between 2024 and 2032 due to the rising incidence of flea and tick-borne diseases in pets.

The chewables segment in the market accounted USD 3.2 billion in 2023, due to their convenience, palatability, and effectiveness.

North America flea and tick control medication market was valued at USD 2.4 billion in 2023, driven by high pet ownership rates, heightened awareness of parasite-related health concerns, and a robust veterinary healthcare infrastructure.

Bayer AG, Boehringer Ingelheim International GmbH, Central Garden & Pet Company, Central Life Sciences, Ceva Sant